Home › All Companies › BIO-B › Annual Report

BIO-RAD LABORATORIES, INC. (BIO-B) — Annual Report

AI-Powered SEC Filing Analysis

← All BIO-B filings
Latest Annual Report Filed: 2026-02-13

Key Insights

  • Bio-Rad Laboratories, Inc. reported stable revenue and profitability in fiscal year 2025, with consistent performance across its key business segments.
  • The company maintained a strong balance sheet, with solid liquidity and manageable debt levels, positioning it well for future investments and growth opportunities.
  • Bio-Rad's research and development spending remained elevated, indicating a focus on innovation and new product development to drive long-term competitiveness.
Sentiment: Positive Significance: 6/10
View Original Filing →

Want the newest filings?

This analysis covers the filing from 2026-02-13. New 10-K, 10-Q and 8-K filings are analyzed the moment they are released — exclusively in the app.

Download on the App Store Open in app →

Other reports for BIO-RAD LABORATORIES, INC.

Current Report Quarterly Report Insider Trading

Important Information

AI-generated analysis is for informational purposes only. Always read original SEC filings and consult with qualified professionals before making investment decisions.